| Tumour exosome integrins determine organotropic metastasis A Hoshino, B Costa-Silva, TL Shen, G Rodrigues, A Hashimoto, ... Nature 527 (7578), 329-335, 2015 | 4514 | 2015 |
| Profound block in thymocyte development in mice lacking p56lck TJ Molina, K Kishihara, DP Siderovskid, W Van Ewijk, A Narendran, ... Nature 357 (6374), 161-164, 1992 | 1209 | 1992 |
| Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 A Rahemtulla, WP Fung-Leung, MW Schilham, TM Kündig, SR Sambhara, ... Nature 353 (6340), 180-184, 1991 | 842 | 1991 |
| Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive … PM Miettunen, A Narendran, A Jayanthan, EM Behrens, RQ Cron Rheumatology 50 (2), 417-419, 2011 | 299 | 2011 |
| Survivin as a preferential target for cancer therapy M Mobahat, A Narendran, K Riabowol International journal of molecular sciences 15 (2), 2494-2516, 2014 | 240 | 2014 |
| Personalizing the treatment of pediatric medulloblastoma: polo-like kinase 1 as a molecular target in high-risk children J Triscott, C Lee, C Foster, B Manoranjan, MR Pambid, R Berns, ... Cancer research 73 (22), 6734-6744, 2013 | 110 | 2013 |
| Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric … R Bagatell, L Gore, MJ Egorin, R Ho, G Heller, N Boucher, EG Zuhowski, ... Clinical Cancer Research 13 (6), 1783-1788, 2007 | 108 | 2007 |
| Systemic vasculitis following influenza vaccination--report of 3 cases and literature review. R Mader, A Narendran, J Lewtas, V Bykerk, RC Goodman, JR Dickson, ... The Journal of Rheumatology 20 (8), 1429-1431, 1993 | 107 | 1993 |
| Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro M Sooriyaarachchi, A Narendran, J Gailer Metallomics 3 (1), 49-55, 2011 | 90 | 2011 |
| Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice C Lee, A Fotovati, J Triscott, J Chen, C Venugopal, A Singhal, C Dunham, ... Stem cells 30 (6), 1064-1075, 2012 | 89 | 2012 |
| Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin H Ganjavi, M Gee, A Narendran, N Parkinson, M Krishnamoorthy, ... Cancer gene therapy 13 (4), 415-419, 2006 | 82 | 2006 |
| A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes T Spence, C Perotti, P Sin-Chan, D Picard, W Wu, A Singh, C Anderson, ... Neuro-oncology 16 (1), 62-71, 2014 | 75 | 2014 |
| A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or … TM Cooper, EAR Sison, SD Baker, L Li, A Ahmed, T Trippett, L Gore, ... Pediatric blood & cancer 64 (8), e26414, 2017 | 72 | 2017 |
| Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth A Narendran, H Ganjavi, N Morson, A Connor, JW Barlow, E Keystone, ... Experimental hematology 31 (8), 693-701, 2003 | 71 | 2003 |
| Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis S Tran, TH Truong, A Narendran European journal of cancer 159, 259-274, 2021 | 64 | 2021 |
| MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL) JC de Oliveira, MS Brassesco, CA Scrideli, LG Tone, A Narendran Pediatric Blood & Cancer 59 (4), 599-604, 2012 | 53 | 2012 |
| EphB receptors trigger Akt activation and suppress Fas receptor-induced apoptosis in malignant T lymphocytes A Maddigan, L Truitt, R Arsenault, T Freywald, O Allonby, J Dean, ... The Journal of Immunology 187 (11), 5983-5994, 2011 | 51 | 2011 |
| The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro M Sooriyaarachchi, A Narendran, J Gailer Metallomics 4 (9), 960-967, 2012 | 50 | 2012 |
| Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin H Ganjavi, M Gee, A Narendran, MH Freedman, D Malkin Cancer Gene Therapy 12 (4), 397-406, 2005 | 48 | 2005 |
| Enzastaurin: A lesson in drug development T Bourhill, A Narendran, RN Johnston Critical reviews in oncology/hematology 112, 72-79, 2017 | 45 | 2017 |
Adam KirtonProfessor of Pediatrics and Clinical Neurosciences, University of CalgaryVerified email at ahs.ca
